Keywords
Last Name
Institution

Steven J. Burakoff

TitleDIRECTOR Tisch Cancer Institute
InstitutionMount Sinai
Address
    Other Positions
    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentOncological Sciences

    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentHematology and Medical Oncology


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Jin YJ, Cai CY, Mezei M, Ohlmeyer M, Sanchez R, Burakoff SJ. Identification of a novel binding site between HIV type 1 Nef C-terminal flexible loop and AP2 required for Nef-mediated CD4 downregulation. AIDS Res Hum Retroviruses. 2013 Apr; 29(4):725-31.
      View in: PubMed
    2. Sawasdikosol S, Zha R, Yang B, Burakoff S. HPK1 as a novel target for cancer immunotherapy. Immunol Res. 2012 Dec; 54(1-3):262-5.
      View in: PubMed
    3. Germain RN, Burakoff SJ. A remembrance of Baruj Benacerraf (AAI '57) 1920-2011. J Immunol. 2011 Dec 1; 187(11):5465-9.
      View in: PubMed
    4. Pedraza-Alva G, Mérida LB, del Rio R, Fierro NA, Cruz-Muñoz ME, Olivares N, Melchy E, Igras V, Holländer GA, Burakoff SJ, Rosenstein Y. CD43 regulates the threshold for T cell activation by targeting Cbl functions. IUBMB Life. 2011 Oct; 63(10):940-8.
      View in: PubMed
    5. Cai CY, Zhang X, Sinko PJ, Burakoff SJ, Jin YJ. Two sorting motifs, a ubiquitination motif and a tyrosine motif, are involved in HIV-1 and simian immunodeficiency virus Nef-mediated receptor endocytosis. J Immunol. 2011 May 15; 186(10):5807-14.
      View in: PubMed
    6. Wang Q, Luan W, Goz V, Burakoff SJ, Hiotis SP. Non-invasive in vivo imaging for liver tumour progression using an orthotopic hepatocellular carcinoma model in immunocompetent mice. Liver Int. 2011 Sep; 31(8):1200-8.
      View in: PubMed
    7. Oh WK, Burakoff SJ. Cancer therapy from bench to bedside. Mt Sinai J Med. 2010 Nov-Dec; 77(6):571-2.
      View in: PubMed
    8. Jin YJ, Zhang X, Cai CY, Burakoff SJ. Alkylating HIV-1 Nef - a potential way of HIV intervention. AIDS Res Ther. 2010; 7:26.
      View in: PubMed
    9. Alzabin S, Pyarajan S, Yee H, Kiefer F, Suzuki A, Burakoff S, Sawasdikosol S. Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response. Cancer Immunol Immunother. 2010 Mar; 59(3):419-29.
      View in: PubMed
    10. Alzabin S, Bhardwaj N, Kiefer F, Sawasdikosol S, Burakoff S. Hematopoietic progenitor kinase 1 is a negative regulator of dendritic cell activation. J Immunol. 2009 May 15; 182(10):6187-94.
      View in: PubMed
    11. Pyarajan S, Matejovic G, Pratt JC, Baksh S, Burakoff SJ. Interleukin-3 (IL-3)-induced c-fos activation is modulated by Gab2-calcineurin interaction. J Biol Chem. 2008 Aug 29; 283(35):23505-9.
      View in: PubMed
    12. Jin YJ, Cai CY, Zhang X, Burakoff SJ. Lysine 144, a ubiquitin attachment site in HIV-1 Nef, is required for Nef-mediated CD4 down-regulation. J Immunol. 2008 Jun 15; 180(12):7878-86.
      View in: PubMed
    13. Sawasdikosol S, Pyarajan S, Alzabin S, Matejovic G, Burakoff SJ. Prostaglandin E2 activates HPK1 kinase activity via a PKA-dependent pathway. J Biol Chem. 2007 Nov 30; 282(48):34693-9.
      View in: PubMed
    14. Mathew JP, Taylor BS, Bader GD, Pyarajan S, Antoniotti M, Chinnaiyan AM, Sander C, Burakoff SJ, Mishra B. From bytes to bedside: data integration and computational biology for translational cancer research. PLoS Comput Biol. 2007 Feb 23; 3(2):e12.
      View in: PubMed
    15. Fragoso RC, Pyarajan S, Irie HY, Burakoff SJ. A CD8/Lck transgene is able to drive thymocyte differentiation. J Immunol. 2006 Nov 1; 177(9):6007-17.
      View in: PubMed
    16. Zambricki E, Shigeoka A, Kishimoto H, Sprent J, Burakoff S, Carpenter C, Milford E, McKay D. Signaling T-cell survival and death by IL-2 and IL-15. Am J Transplant. 2005 Nov; 5(11):2623-31.
      View in: PubMed
    17. Jin YJ, Cai CY, Zhang X, Zhang HT, Hirst JA, Burakoff SJ. HIV Nef-mediated CD4 down-regulation is adaptor protein complex 2 dependent. J Immunol. 2005 Sep 1; 175(5):3157-64.
      View in: PubMed
    18. Jin YJ, Zhang X, Boursiquot JG, Burakoff SJ. CD4 phosphorylation partially reverses Nef down-regulation of CD4. J Immunol. 2004 Nov 1; 173(9):5495-500.
      View in: PubMed
    19. Su MW, Pyarajan S, Chang JH, Yu CL, Jin YJ, Stierhof YD, Walden P, Burakoff SJ. Fratricide of CD8+ cytotoxic T lymphocytes is dependent on cellular activation and perforin-mediated killing. Eur J Immunol. 2004 Sep; 34(9):2459-70.
      View in: PubMed
    20. Friedman JS, Alpdogan O, van den Brink MR, Liu C, Hurwitz D, Boyd A, Kupper TS, Burakoff SJ. Increasing T-cell age reduces effector activity but preserves proliferative capacity in a murine allogeneic major histocompatibility complex-mismatched bone marrow transplant model. Biol Blood Marrow Transplant. 2004 Jul; 10(7):448-60.
      View in: PubMed
    21. Frazer-Abel AA, Baksh S, Fosmire SP, Willis D, Pierce AM, Meylemans H, Linthicum DS, Burakoff SJ, Coons T, Bellgrau D, Modiano JF. Nicotine activates nuclear factor of activated T cells c2 (NFATc2) and prevents cell cycle entry in T cells. J Pharmacol Exp Ther. 2004 Nov; 311(2):758-69.
      View in: PubMed
    22. Friedman JS, Lopez MF, Fleming MD, Rivera A, Martin FM, Welsh ML, Boyd A, Doctrow SR, Burakoff SJ. SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness. Blood. 2004 Oct 15; 104(8):2565-73.
      View in: PubMed
    23. Slavik JM, Lim DG, Burakoff SJ, Hafler DA. Rapamycin-resistant proliferation of CD8+ T cells correlates with p27kip1 down-regulation and bcl-xL induction, and is prevented by an inhibitor of phosphoinositide 3-kinase activity. J Biol Chem. 2004 Jan 9; 279(2):910-9.
      View in: PubMed
    24. Fragoso R, Ren D, Zhang X, Su MW, Burakoff SJ, Jin YJ. Lipid raft distribution of CD4 depends on its palmitoylation and association with Lck, and evidence for CD4-induced lipid raft aggregation as an additional mechanism to enhance CD3 signaling. J Immunol. 2003 Jan 15; 170(2):913-21.
      View in: PubMed
    25. Sawasdikosol S, Russo KM, Burakoff SJ. Hematopoietic progenitor kinase 1 (HPK1) negatively regulates prostaglandin E2-induced fos gene transcription. Blood. 2003 May 1; 101(9):3687-9.
      View in: PubMed
    26. Baksh S, Widlund HR, Frazer-Abel AA, Du J, Fosmire S, Fisher DE, DeCaprio JA, Modiano JF, Burakoff SJ. NFATc2-mediated repression of cyclin-dependent kinase 4 expression. Mol Cell. 2002 Nov; 10(5):1071-81.
      View in: PubMed
    27. Ordemann R, Hutchinson R, Friedman J, Burakoff SJ, Reddy P, Duffner U, Braun TM, Liu C, Teshima T, Ferrara JL. Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. J Clin Invest. 2002 May; 109(9):1249-56.
      View in: PubMed
    28. van den Brink MR, Burakoff SJ. Cytolytic pathways in haematopoietic stem-cell transplantation. Nat Rev Immunol. 2002 Apr; 2(4):273-81.
      View in: PubMed
    29. Mulroy T, McMahon JA, Burakoff SJ, McMahon AP, Sen J. Wnt-1 and Wnt-4 regulate thymic cellularity. Eur J Immunol. 2002 Apr; 32(4):967-71.
      View in: PubMed
    30. Tkaczuk J, Yu CL, Baksh S, Milford EL, Carpenter CB, Burakoff SJ, McKay DB. Effect of anti-IL-2Ralpha antibody on IL-2-induced Jak/STAT signaling. Am J Transplant. 2002 Jan; 2(1):31-40.
      View in: PubMed
    31. Schmaltz C, Alpdogan O, Horndasch KJ, Muriglan SJ, Kappel BJ, Teshima T, Ferrara JL, Burakoff SJ, van den Brink MR. Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect. Blood. 2001 May 1; 97(9):2886-95.
      View in: PubMed
    32. Friedman JS, Rebel VI, Derby R, Bell K, Huang TT, Kuypers FA, Epstein CJ, Burakoff SJ. Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant. J Exp Med. 2001 Apr 16; 193(8):925-34.
      View in: PubMed
    33. Su MW, Yu CL, Burakoff SJ, Jin YJ. Targeting Src homology 2 domain-containing tyrosine phosphatase (SHP-1) into lipid rafts inhibits CD3-induced T cell activation. J Immunol. 2001 Mar 15; 166(6):3975-82.
      View in: PubMed
    34. Slavik JM, Lim DG, Burakoff SJ, Hafler DA. Uncoupling p70(s6) kinase activation and proliferation: rapamycin-resistant proliferation of human CD8(+) T lymphocytes. J Immunol. 2001 Mar 1; 166(5):3201-9.
      View in: PubMed
    35. Tkaczuk J, Milford E, Yu C, Baksh S, Carpenter C, Burakoff S, McKay D. Intracellular signaling consequences of anti-IL-2Ralpha blockade by daclizumab. Transplant Proc. 2001 Feb-Mar; 33(1-2):212-3.
      View in: PubMed
    36. Pedraza-Alva G, Sawasdikosol S, Liu YC, Mérida LB, Cruz-Muñoz ME, Oceguera-Yañez F, Burakoff SJ, Rosenstein Y. Regulation of Cbl molecular interactions by the co-receptor molecule CD43 in human T cells. J Biol Chem. 2001 Jan 5; 276(1):729-37.
      View in: PubMed
    37. Pratt JC, Igras VE, Maeda H, Baksh S, Gelfand EW, Burakoff SJ, Neel BG, Gu H. Cutting edge: gab2 mediates an inhibitory phosphatidylinositol 3'-kinase pathway in T cell antigen receptor signaling. J Immunol. 2000 Oct 15; 165(8):4158-63.
      View in: PubMed
    38. Santana MA, Pedraza-Alva G, Olivares-Zavaleta N, Madrid-Marina V, Horejsi V, Burakoff SJ, Rosenstein Y. CD43-mediated signals induce DNA binding activity of AP-1, NF-AT, and NFkappa B transcription factors in human T lymphocytes. J Biol Chem. 2000 Oct 6; 275(40):31460-8.
      View in: PubMed
    39. Nishikawa K, Sawasdikosol S, Fruman DA, Lai J, Songyang Z, Burakoff SJ, Yaffe MB, Cantley LC. A peptide library approach identifies a specific inhibitor for the ZAP-70 protein tyrosine kinase. Mol Cell. 2000 Oct; 6(4):969-74.
      View in: PubMed
    40. Baksh S, Burakoff SJ. The role of calcineurin in lymphocyte activation. Semin Immunol. 2000 Aug; 12(4):405-15.
      View in: PubMed
    41. Sawasdikosol S, Pratt JC, Meng W, Eck MJ, Burakoff SJ. Adapting to multiple personalities: Cbl is also a RING finger ubiquitin ligase. Biochim Biophys Acta. 2000 Jul 31; 1471(1):M1-M12.
      View in: PubMed
    42. van den Brink MR, Moore E, Horndasch KJ, Crawford JM, Murphy GF, Burakoff SJ. Fas ligand-deficient gld mice are more susceptible to graft-versus-host-disease. Transplantation. 2000 Jul 15; 70(1):184-91.
      View in: PubMed
    43. Baksh S, DeCaprio JA, Burakoff SJ. Calcineurin regulation of the mammalian G0/G1 checkpoint element, cyclin dependent kinase 4. Oncogene. 2000 Jun 1; 19(24):2820-7.
      View in: PubMed
    44. van den Brink MR, Moore E, Ferrara JL, Burakoff SJ. Graft-versus-host-disease-associated thymic damage results in the appearance of T cell clones with anti-host reactivity. Transplantation. 2000 Feb 15; 69(3):446-9.
      View in: PubMed
    45. Yu CL, Jin YJ, Burakoff SJ. Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation. J Biol Chem. 2000 Jan 7; 275(1):599-604.
      View in: PubMed
    46. van Den Brink MR, Moore E, Horndasch KJ, Crawford JM, Hoffman J, Murphy GF, Burakoff SJ. Fas-deficient lpr mice are more susceptible to graft-versus-host disease. J Immunol. 2000 Jan 1; 164(1):469-80.
      View in: PubMed
    47. McKay DB, Irie HY, Hollander G, Ferrara JL, Strom TB, Li Y, Burakoff SJ. Antigen-induced unresponsiveness results in altered T cell signaling. J Immunol. 1999 Dec 15; 163(12):6455-61.
      View in: PubMed
    48. Jin YJ, Yu CL, Burakoff SJ. Human 70-kDa SHP-1L differs from 68-kDa SHP-1 in its C-terminal structure and catalytic activity. J Biol Chem. 1999 Oct 1; 274(40):28301-7.
      View in: PubMed
    49. Pratt JC, van den Brink MR, Igras VE, Walk SF, Ravichandran KS, Burakoff SJ. Requirement for Shc in TCR-mediated activation of a T cell hybridoma. J Immunol. 1999 Sep 1; 163(5):2586-91.
      View in: PubMed
    50. Tang J, Sawasdikosol S, Chang JH, Burakoff SJ. SLAP, a dimeric adapter protein, plays a functional role in T cell receptor signaling. Proc Natl Acad Sci U S A. 1999 Aug 17; 96(17):9775-80.
      View in: PubMed
    51. van den Brink MR, Kapeller R, Pratt JC, Chang JH, Burakoff SJ. The extracellular signal-regulated kinase pathway is required for activation-induced cell death of T cells. J Biol Chem. 1999 Apr 16; 274(16):11178-85.
      View in: PubMed
    52. Meng W, Sawasdikosol S, Burakoff SJ, Eck MJ. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase. Nature. 1999 Mar 4; 398(6722):84-90.
      View in: PubMed
    53. Pratt JC, Sawasdikosol S, van den Brink MR, Burakoff SJ. Positive and negative signaling pathways. Transplant Proc. 1999 Feb-Mar; 31(1-2):772-4.
      View in: PubMed
    54. Gu H, Pratt JC, Burakoff SJ, Neel BG. Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation. Mol Cell. 1998 Dec; 2(6):729-40.
      View in: PubMed
    55. Chang JH, Pratt JC, Sawasdikosol S, Kapeller R, Burakoff SJ. The small GTP-binding protein Rho potentiates AP-1 transcription in T cells. Mol Cell Biol. 1998 Sep; 18(9):4986-93.
      View in: PubMed
    56. Jin YJ, Friedman J, Burakoff SJ. Regulation of tyrosine phosphorylation in isolated T cell membrane by inhibition of protein tyrosine phosphatases. J Immunol. 1998 Aug 15; 161(4):1743-50.
      View in: PubMed
    57. Irie HY, Mong MS, Itano A, Crooks ME, Littman DR, Burakoff SJ, Robey E. The cytoplasmic domain of CD8 beta regulates Lck kinase activation and CD8 T cell development. J Immunol. 1998 Jul 1; 161(1):183-91.
      View in: PubMed
    58. Pedraza-Alva G, Mérida LB, Burakoff SJ, Rosenstein Y. T cell activation through the CD43 molecule leads to Vav tyrosine phosphorylation and mitogen-activated protein kinase pathway activation. J Biol Chem. 1998 Jun 5; 273(23):14218-24.
      View in: PubMed
    59. Holländer GA, Zuklys S, Morel C, Mizoguchi E, Mobisson K, Simpson S, Terhorst C, Wishart W, Golan DE, Bhan AK, Burakoff SJ. Monoallelic expression of the interleukin-2 locus. Science. 1998 Mar 27; 279(5359):2118-21.
      View in: PubMed
    60. Yu CL, Jove R, Burakoff SJ. Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase. J Immunol. 1997 Dec 1; 159(11):5206-10.
      View in: PubMed
    61. Ravichandran KS, Zhou MM, Pratt JC, Harlan JE, Walk SF, Fesik SW, Burakoff SJ. Evidence for a requirement for both phospholipid and phosphotyrosine binding via the Shc phosphotyrosine-binding domain in vivo. Mol Cell Biol. 1997 Sep; 17(9):5540-9.
      View in: PubMed
    62. Rameh LE, Arvidsson Ak, Carraway KL, Couvillon AD, Rathbun G, Crompton A, VanRenterghem B, Czech MP, Ravichandran KS, Burakoff SJ, Wang DS, Chen CS, Cantley LC. A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J Biol Chem. 1997 Aug 29; 272(35):22059-66.
      View in: PubMed
    63. Yu CL, Burakoff SJ. Involvement of proteasomes in regulating Jak-STAT pathways upon interleukin-2 stimulation. J Biol Chem. 1997 May 30; 272(22):14017-20.
      View in: PubMed
    64. Pedraza-Alva G, Mérida LB, Burakoff SJ, Rosenstein Y. CD43-specific activation of T cells induces association of CD43 to Fyn kinase. J Biol Chem. 1996 Nov 1; 271(44):27564-8.
      View in: PubMed
    65. Lee-Fruman KK, Collins TL, Burakoff SJ. Role of the Lck Src homology 2 and 3 domains in protein tyrosine phosphorylation. J Biol Chem. 1996 Oct 4; 271(40):25003-10.
      View in: PubMed
    66. Lorenz U, Ravichandran KS, Burakoff SJ, Neel BG. Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness. Proc Natl Acad Sci U S A. 1996 Sep 3; 93(18):9624-9.
      View in: PubMed
    67. Sawasdikosol S, Chang JH, Pratt JC, Wolf G, Shoelson SE, Burakoff SJ. Tyrosine-phosphorylated Cbl binds to Crk after T cell activation. J Immunol. 1996 Jul 1; 157(1):110-6.
      View in: PubMed
    68. Sen J, Kapeller R, Fragoso R, Sen R, Zon LI, Burakoff SJ. Intrathymic signals in thymocytes are mediated by p38 mitogen-activated protein kinase. J Immunol. 1996 Jun 15; 156(12):4535-8.
      View in: PubMed
    69. Wang B, Hollander GA, Nichogiannopoulou A, Simpson SJ, Orange JS, Gutierrez-Ramos JC, Burakoff SJ, Biron CA, Terhorst C. Natural killer cell development is blocked in the context of aberrant T lymphocyte ontogeny. Int Immunol. 1996 Jun; 8(6):939-49.
      View in: PubMed
    70. Ravichandran KS, Igras V, Shoelson SE, Fesik SW, Burakoff SJ. Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling. Proc Natl Acad Sci U S A. 1996 May 28; 93(11):5275-80.
      View in: PubMed
    71. Pratt JC, Weiss M, Sieff CA, Shoelson SE, Burakoff SJ, Ravichandran KS. Evidence for a physical association between the Shc-PTB domain and the beta c chain of the granulocyte-macrophage colony-stimulating factor receptor. J Biol Chem. 1996 May 24; 271(21):12137-40.
      View in: PubMed
    72. Holländer GA, Castigli E, Kulbacki R, Su M, Burakoff SJ, Gutierrez-Ramos JC, Geha RS. Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice. Proc Natl Acad Sci U S A. 1996 May 14; 93(10):4994-8.
      View in: PubMed
    73. Dunussi-Joannopoulos K, Weinstein HJ, Nickerson PW, Strom TB, Burakoff SJ, Croop JM, Arceci RJ. Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AML. Blood. 1996 Apr 1; 87(7):2938-46.
      View in: PubMed
    74. Wesselborg S, Fruman DA, Sagoo JK, Bierer BE, Burakoff SJ. Identification of a physical interaction between calcineurin and nuclear factor of activated T cells (NFATp). J Biol Chem. 1996 Jan 19; 271(3):1274-7.
      View in: PubMed
    75. Ravichandran KS, Collins TL, Burakoff SJ. CD4 and signal transduction. Curr Top Microbiol Immunol. 1996; 205:47-62.
      View in: PubMed
    76. Zhou MM, Harlan JE, Wade WS, Crosby S, Ravichandran KS, Burakoff SJ, Fesik SW. Binding affinities of tyrosine-phosphorylated peptides to the COOH-terminal SH2 and NH2-terminal phosphotyrosine binding domains of Shc. J Biol Chem. 1995 Dec 29; 270(52):31119-23.
      View in: PubMed
    77. Zhou MM, Ravichandran KS, Olejniczak EF, Petros AM, Meadows RP, Sattler M, Harlan JE, Wade WS, Burakoff SJ, Fesik SW. Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Nature. 1995 Dec 7; 378(6557):584-92.
      View in: PubMed
    78. Ravichandran KS, Pratt JC, Sawasdikosol S, Irie HY, Burakoff SJ. Coreceptors and adapter proteins in T-cell signaling. Ann N Y Acad Sci. 1995 Sep 7; 766:117-33.
      View in: PubMed
    79. Ravichandran KS, Lorenz U, Shoelson SE, Burakoff SJ. Interaction of Shc with Grb2 regulates the Grb2 association with mSOS. Ann N Y Acad Sci. 1995 Sep 7; 766:202-3.
      View in: PubMed
    80. Zhou MM, Meadows RP, Logan TM, Yoon HS, Wade WS, Ravichandran KS, Burakoff SJ, Fesik SW. Solution structure of the Shc SH2 domain complexed with a tyrosine-phosphorylated peptide from the T-cell receptor. Proc Natl Acad Sci U S A. 1995 Aug 15; 92(17):7784-8.
      View in: PubMed
    81. Fruman DA, Pai SY, Burakoff SJ, Bierer BE. Characterization of a mutant calcineurin A alpha gene expressed by EL4 lymphoma cells. Mol Cell Biol. 1995 Jul; 15(7):3857-63.
      View in: PubMed
    82. Holländer GA, Simpson SJ, Mizoguchi E, Nichogiannopoulou A, She J, Gutierrez-Ramos JC, Bhan AK, Burakoff SJ, Wang B, Terhorst C. Severe colitis in mice with aberrant thymic selection. Immunity. 1995 Jul; 3(1):27-38.
      View in: PubMed
    83. Sen J, Venkataraman L, Shinkai Y, Pierce JW, Alt FW, Burakoff SJ, Sen R. Expression and induction of nuclear factor-kappa B-related proteins in thymocytes. J Immunol. 1995 Apr 1; 154(7):3213-21.
      View in: PubMed
    84. Irie HY, Ravichandran KS, Burakoff SJ. CD8 beta chain influences CD8 alpha chain-associated Lck kinase activity. J Exp Med. 1995 Apr 1; 181(4):1267-73.
      View in: PubMed
    85. Venkataraman L, Burakoff SJ, Sen R. FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. J Exp Med. 1995 Mar 1; 181(3):1091-9.
      View in: PubMed
    86. Sawasdikosol S, Ravichandran KS, Lee KK, Chang JH, Burakoff SJ. Crk interacts with tyrosine-phosphorylated p116 upon T cell activation. J Biol Chem. 1995 Feb 17; 270(7):2893-6.
      View in: PubMed
    87. Fruman DA, Bierer BE, Benes JE, Burakoff SJ, Austen KF, Katz HR. The complex of FK506-binding protein 12 and FK506 inhibits calcineurin phosphatase activity and IgE activation-induced cytokine transcripts, but not exocytosis, in mouse mast cells. J Immunol. 1995 Feb 15; 154(4):1846-51.
      View in: PubMed
    88. Ravichandran KS, Lorenz U, Shoelson SE, Burakoff SJ. Interaction of Shc with Grb2 regulates association of Grb2 with mSOS. Mol Cell Biol. 1995 Feb; 15(2):593-600.
      View in: PubMed
    89. Fruman DA, Wood MA, Gjertson CK, Katz HR, Burakoff SJ, Bierer BE. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells. Eur J Immunol. 1995 Feb; 25(2):563-71.
      View in: PubMed
    90. Holländer GA, Wang B, Nichogiannopoulou A, Platenburg PP, van Ewijk W, Burakoff SJ, Gutierrez-Ramos JC, Terhorst C. Developmental control point in induction of thymic cortex regulated by a subpopulation of prothymocytes. Nature. 1995 Jan 26; 373(6512):350-3.
      View in: PubMed
    91. Sen J, Shinkai Y, Alt FW, Sen R, Burakoff SJ. Nuclear factors that mediate intrathymic signals are developmentally regulated. J Exp Med. 1994 Dec 1; 180(6):2321-7.
      View in: PubMed
    92. Holländer GA, Fruman DA, Bierer BE, Burakoff SJ. Disruption of T cell development and repertoire selection by calcineurin inhibition in vivo. Transplantation. 1994 Nov 15; 58(9):1037-43.
      View in: PubMed
    93. Holländer GA, Bierer BE, Burakoff SJ. Molecular and biological actions of cyclosporin A and FK506 on T cell development and function. Transfus Sci. 1994 Sep; 15(3):207-20.
      View in: PubMed
    94. Collins TL, Kassner PD, Bierer BE, Burakoff SJ. Adhesion receptors in lymphocyte activation. Curr Opin Immunol. 1994 Jun; 6(3):385-93.
      View in: PubMed
    95. Fruman DA, Burakoff SJ, Bierer BE. Immunophilins in protein folding and immunosuppression. FASEB J. 1994 Apr 1; 8(6):391-400.
      View in: PubMed
    96. Lorenz U, Ravichandran KS, Pei D, Walsh CT, Burakoff SJ, Neel BG. Lck-dependent tyrosyl phosphorylation of the phosphotyrosine phosphatase SH-PTP1 in murine T cells. Mol Cell Biol. 1994 Mar; 14(3):1824-34.
      View in: PubMed
    97. Holländer GA, Widmer B, Burakoff SJ. Loss of normal thymic repertoire selection and persistence of autoreactive T cells in graft vs host disease. J Immunol. 1994 Feb 15; 152(4):1609-17.
      View in: PubMed
    98. Ravichandran KS, Burakoff SJ. Evidence for differential intracellular signaling via CD4 and CD8 molecules. J Exp Med. 1994 Feb 1; 179(2):727-32.
      View in: PubMed
    99. Ravichandran KS, Burakoff SJ. The adapter protein Shc interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation. J Biol Chem. 1994 Jan 21; 269(3):1599-602.
      View in: PubMed
    100. Collins TL, Burakoff SJ. Tyrosine kinase activity of CD4-associated p56lck may not be required for CD4-dependent T-cell activation. Proc Natl Acad Sci U S A. 1993 Dec 15; 90(24):11885-9.
      View in: PubMed
    101. Hendrickson BA, Zhang W, Craig RJ, Jin YJ, Bierer BE, Burakoff S, DiLella AG. Structural organization of the genes encoding human and murine FK506-binding protein (FKBP) 13 and comparison to FKBP1. Gene. 1993 Dec 8; 134(2):271-5.
      View in: PubMed
    102. Ravichandran KS, Lee KK, Songyang Z, Cantley LC, Burn P, Burakoff SJ. Interaction of Shc with the zeta chain of the T cell receptor upon T cell activation. Science. 1993 Nov 5; 262(5135):902-5.
      View in: PubMed
    103. Burakoff SJ, Lafferty KJ. Transplantation. Antigen, co-stimulators and cytokines: regulators of allogeneic interactions. Curr Opin Immunol. 1993 Oct; 5(5):745-6.
      View in: PubMed
    104. Bierer BE, Holländer G, Fruman D, Burakoff SJ. Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology. Curr Opin Immunol. 1993 Oct; 5(5):763-73.
      View in: PubMed
    105. Nigam SK, Jin YJ, Jin MJ, Bush KT, Bierer BE, Burakoff SJ. Localization of the FK506-binding protein, FKBP 13, to the lumen of the endoplasmic reticulum. Biochem J. 1993 Sep 1; 294 ( Pt 2):511-5.
      View in: PubMed
    106. Jin YJ, Burakoff SJ. The 25-kDa FK506-binding protein is localized in the nucleus and associates with casein kinase II and nucleolin. Proc Natl Acad Sci U S A. 1993 Aug 15; 90(16):7769-73.
      View in: PubMed
    107. Macklis RM, Mauch PM, Thompson L, Burakoff SJ, Smith BR. Phenotypic and functional analysis of expanded natural killer cell subpopulations in Hodgkin's disease patients treated with lymphoid irradiation. Oncology. 1993 Jul-Aug; 50(4):323-8.
      View in: PubMed
    108. Hahn WC, Burakoff SJ, Bierer BE. Signal transduction pathways involved in T cell receptor-induced regulation of CD2 avidity for CD58. J Immunol. 1993 Apr 1; 150(7):2607-19.
      View in: PubMed
    109. Dutz JP, Fruman DA, Burakoff SJ, Bierer BE. A role for calcineurin in degranulation of murine cytotoxic T lymphocytes. J Immunol. 1993 Apr 1; 150(7):2591-8.
      View in: PubMed
    110. Collins TL, Hahn WC, Bierer BE, Burakoff SJ. CD4, CD8 and CD2 in T cell adhesion and signaling. Curr Top Microbiol Immunol. 1993; 184:223-33.
      View in: PubMed
    111. Fruman DA, Mather PE, Burakoff SJ, Bierer BE. Correlation of calcineurin phosphatase activity and programmed cell death in murine T cell hybridomas. Eur J Immunol. 1992 Oct; 22(10):2513-7.
      View in: PubMed
    112. Sleckman BP, Shin J, Igras VE, Collins TL, Strominger JL, Burakoff SJ. Disruption of the CD4-p56lck complex is required for rapid internalization of CD4. Proc Natl Acad Sci U S A. 1992 Aug 15; 89(16):7566-70.
      View in: PubMed
    113. Hahn WC, Rosenstein Y, Calvo V, Burakoff SJ, Bierer BE. A distinct cytoplasmic domain of CD2 regulates ligand avidity and T-cell responsiveness to antigen. Proc Natl Acad Sci U S A. 1992 Aug 1; 89(15):7179-83.
      View in: PubMed
    114. Holländer GA, Luskey BD, Williams DA, Burakoff SJ. Functional expression of human CD8 in fully reconstituted mice after retroviral-mediated gene transfer of hemopoietic stem cells. J Immunol. 1992 Jul 15; 149(2):438-44.
      View in: PubMed
    115. Jin YJ, Burakoff SJ, Bierer BE. Molecular cloning of a 25-kDa high affinity rapamycin binding protein, FKBP25. J Biol Chem. 1992 Jun 5; 267(16):10942-5.
      View in: PubMed
    116. Moore JP, Simpson G, McKeating JA, Burakoff SJ, Schreiber SL, Weiss RA. CPF-DD is an inhibitor of infection by human immunodeficiency virus and other enveloped viruses in vitro. Virology. 1992 Jun; 188(2):537-44.
      View in: PubMed
    117. Fruman DA, Klee CB, Bierer BE, Burakoff SJ. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci U S A. 1992 May 1; 89(9):3686-90.
      View in: PubMed
    118. Collins TL, Uniyal S, Shin J, Strominger JL, Mittler RS, Burakoff SJ. p56lck association with CD4 is required for the interaction between CD4 and the TCR/CD3 complex and for optimal antigen stimulation. J Immunol. 1992 Apr 1; 148(7):2159-62.
      View in: PubMed
    119. Goldman SJ, Uniyal S, Ferguson LM, Golan DE, Burakoff SJ, Kiener PA. Differential activation of phosphotyrosine protein phosphatase activity in a murine T cell hybridoma by monoclonal antibodies to CD45. J Biol Chem. 1992 Mar 25; 267(9):6197-204.
      View in: PubMed
    120. Sen J, Bossu P, Burakoff SJ, Abbas AK. T cell surface molecules regulating noncognate B lymphocyte activation. Role of CD2 and LFA-1. J Immunol. 1992 Feb 15; 148(4):1037-42.
      View in: PubMed
    121. Macklis RM, Mauch PM, Burakoff SJ, Smith BR. Lymphoid irradiation results in long-term increases in natural killer cells in patients treated for Hodgkin's disease. Cancer. 1992 Feb 1; 69(3):778-83.
      View in: PubMed
    122. Bierer BE, Jin YJ, Fruman DA, Calvo V, Burakoff SJ. FK 506 and rapamycin: molecular probes of T-lymphocyte activation. Transplant Proc. 1991 Dec; 23(6):2850-5.
      View in: PubMed
    123. Sakamoto H, Michaelson J, Jones WK, Bhan AK, Abhyankar S, Silverstein M, Golan DE, Burakoff SJ, Ferrara JL. Lymphocytes with a CD4+ CD8- CD3- phenotype are effectors of experimental cutaneous graft-versus-host disease. Proc Natl Acad Sci U S A. 1991 Dec 1; 88(23):10890-4.
      View in: PubMed
    124. Rosenstein Y, Park JK, Hahn WC, Rosen FS, Bierer BE, Burakoff SJ. CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1. Nature. 1991 Nov 21; 354(6350):233-5.
      View in: PubMed
    125. McCarthy PL, Abhyankar S, Neben S, Newman G, Sieff C, Thompson RC, Burakoff SJ, Ferrara JL. Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease. Blood. 1991 Oct 15; 78(8):1915-8.
      View in: PubMed
    126. Jin YJ, Albers MW, Lane WS, Bierer BE, Schreiber SL, Burakoff SJ. Molecular cloning of a membrane-associated human FK506- and rapamycin-binding protein, FKBP-13. Proc Natl Acad Sci U S A. 1991 Aug 1; 88(15):6677-81.
      View in: PubMed
    127. Sleckman BP, Rosenstein Y, Igras VE, Greenstein JL, Burakoff SJ. Glycolipid-anchored form of CD4 increases intercellular adhesion but is unable to enhance T cell activation. J Immunol. 1991 Jul 15; 147(2):428-31.
      View in: PubMed
    128. Hahn WC, Rosenstein Y, Burakoff SJ, Bierer BE. Interaction of CD2 with its ligand lymphocyte function-associated antigen-3 induces adenosine 3',5'-cyclic monophosphate production in T lymphocytes. J Immunol. 1991 Jul 1; 147(1):14-21.
      View in: PubMed
    129. Silberman SL, Goldman SJ, Mitchell DB, Tong AT, Rosenstein Y, Diamond DC, Finberg RW, Schreiber SL, Burakoff SJ. The interaction of CD4 with HIV-1 gp120. Semin Immunol. 1991 May; 3(3):187-92.
      View in: PubMed
    130. Park JK, Rosenstein YJ, Remold-O'Donnell E, Bierer BE, Rosen FS, Burakoff SJ. Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott-Aldrich syndrome. Nature. 1991 Apr 25; 350(6320):706-9.
      View in: PubMed
    131. Maziarz RT, Groh V, Prendergast M, Fabbi M, Strominger JL, Burakoff SJ. Non-MHC-restricted target-cell lysis by a CD4-CD8- TCR alpha beta T-cell line, as well as by TCR gamma delta T-cell lines, results from lymphokine-activated killing. Int J Cancer. 1991 Apr 22; 48(1):142-7.
      View in: PubMed
    132. Rimm IJ, Ghayur T, Gasser DL, Rosenkrantz K, Burakoff SJ, Seidman JG, Ferrara JL. Alloreactive lymphocytes from T cell receptor (beta-chain) transgenic mice do not mediate a graft-versus-host reaction. J Immunol. 1991 Feb 15; 146(4):1130-3.
      View in: PubMed
    133. Bierer BE, Schreiber SL, Burakoff SJ. The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation. Eur J Immunol. 1991 Feb; 21(2):439-45.
      View in: PubMed
    134. Sékaly RP, Croteau G, Bowman M, Scholl P, Burakoff S, Geha RS. The CD4 molecule is not always required for the T cell response to bacterial enterotoxins. J Exp Med. 1991 Feb 1; 173(2):367-71.
      View in: PubMed
    135. Bierer BE, Burakoff SJ. T cell receptors: adhesion and signaling. Adv Cancer Res. 1991; 56:49-76.
      View in: PubMed
    136. Bierer BE, Mattila PS, Standaert RF, Herzenberg LA, Burakoff SJ, Crabtree G, Schreiber SL. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc Natl Acad Sci U S A. 1990 Dec; 87(23):9231-5.
      View in: PubMed
    137. Bowman MR, MacFerrin KD, Schreiber SL, Burakoff SJ. Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules. Proc Natl Acad Sci U S A. 1990 Nov; 87(22):9052-6.
      View in: PubMed
    138. Bierer BE, Somers PK, Wandless TJ, Burakoff SJ, Schreiber SL. Probing immunosuppressant action with a nonnatural immunophilin ligand. Science. 1990 Oct 26; 250(4980):556-9.
      View in: PubMed
    139. Maziarz RT, Mentzer SJ, Burakoff SJ, Faller DV. Distinct effects of interferon-gamma and MHC class I surface antigen levels on resistance of the K562 tumor cell line to natural killer-mediated lysis. Cell Immunol. 1990 Oct 15; 130(2):329-38.
      View in: PubMed
    140. Finberg RW, Diamond DC, Mitchell DB, Rosenstein Y, Soman G, Norman TC, Schreiber SL, Burakoff SJ. Prevention of HIV-1 infection and preservation of CD4 function by the binding of CPFs to gp120. Science. 1990 Jul 20; 249(4966):287-91.
      View in: PubMed
    141. Diamond DC, Finberg R, Chaudhuri S, Sleckman BP, Burakoff SJ. Human immunodeficiency virus infection is efficiently mediated by a glycolipid-anchored form of CD4. Proc Natl Acad Sci U S A. 1990 Jul; 87(13):5001-5.
      View in: PubMed
    142. Veillette A, Sleckman BP, Ratnofsky S, Bolen JB, Burakoff SJ. The cytoplasmic domain of CD4 is required for stable association with the lymphocyte-specific tyrosine protein kinase p56lck. Eur J Immunol. 1990 Jun; 20(6):1397-400.
      View in: PubMed
    143. Bierer BE, Schreiber SL, Burakoff SJ. Mechanisms of immunosuppression by FK506. Preservation of T cell transmembrane signal transduction. Transplantation. 1990 Jun; 49(6):1168-70.
      View in: PubMed
    144. van Dijken PJ, Ghayur T, Mauch P, Down J, Burakoff SJ, Ferrara JL. Evidence that anti-LFA-1 in vivo improves engraftment and survival after allogeneic bone marrow transplantation. Transplantation. 1990 May; 49(5):882-6.
      View in: PubMed
    145. Sen J, Rosenberg N, Burakoff SJ. Expression and ontogeny of CD2 on murine B cells. J Immunol. 1990 Apr 15; 144(8):2925-30.
      View in: PubMed
    146. Wolff HL, Burakoff SJ, Bierer BE. Functional CD2 mutants unable to bind to, or be stimulated by, LFA-3. J Immunol. 1990 Feb 15; 144(4):1215-20.
      View in: PubMed
    147. Bierer BE, Bogart RE, Burakoff SJ. Partial deletions of the cytoplasmic domain of CD2 result in a partial defect in signal transduction. J Immunol. 1990 Feb 1; 144(3):785-9.
      View in: PubMed
    148. Maziarz RT, Burakoff SJ, Faller DV. The regulation of exogenous and endogenous class I MHC genes in a human tumor cell line, K562. Mol Immunol. 1990 Feb; 27(2):135-42.
      View in: PubMed
    149. Rosenstein Y, Burakoff SJ, Herrmann SH. HIV-gp120 can block CD4-class II MHC-mediated adhesion. J Immunol. 1990 Jan 15; 144(2):526-31.
      View in: PubMed
    150. Mentzer SJ, Burakoff SJ, Barbosa JA. Induction of HLA class I surface expression recruits low-affinity cytolytic T lymphocytes. Int Arch Allergy Appl Immunol. 1990; 91(4):437-40.
      View in: PubMed
    151. Ferrara JL, Mauch P, Van Dijken PJ, Crosier KE, Michaelson J, Burakoff SJ. Evidence that anti-asialo GM1 in vivo improves engraftment of T cell-depleted bone marrow in hybrid recipients. Transplantation. 1990 Jan; 49(1):134-8.
      View in: PubMed
    152. Mittler RS, Goldman SJ, Spitalny GL, Burakoff SJ. T-cell receptor-CD4 physical association in a murine T-cell hybridoma: induction by antigen receptor ligation. Proc Natl Acad Sci U S A. 1989 Nov; 86(21):8531-5.
      View in: PubMed
    153. Santos-Aguado J, Crimmins MA, Mentzer SJ, Burakoff SJ, Strominger JL. Alloreactivity studied with mutants of HLA-A2. Proc Natl Acad Sci U S A. 1989 Nov; 86(22):8936-40.
      View in: PubMed
    154. Bierer BE, Burakoff SJ. T-lymphocyte activation: the biology and function of CD2 and CD4. Immunol Rev. 1989 Oct; 111:267-94.
      View in: PubMed
    155. Sen J, Arceci RJ, Jones W, Burakoff SJ. Expression and ontogeny of murine CD2. Eur J Immunol. 1989 Jul; 19(7):1297-302.
      View in: PubMed
    156. Macklis RM, Kaplan WD, Ferrara JL, Atcher RW, Hines JJ, Burakoff SJ, Coleman CN. Alpha particle radio-immunotherapy: animal models and clinical prospects. Int J Radiat Oncol Biol Phys. 1989 Jun; 16(6):1377-87.
      View in: PubMed
    157. Bierer BE, Burakoff SJ, Smith BR. A large proportion of T lymphocytes lack CD5 expression after bone marrow transplantation. Blood. 1989 Apr; 73(5):1359-66.
      View in: PubMed
    158. Bierer BE, Golan DE, Brown CS, Herrmann SH, Burakoff SJ. A monoclonal antibody to LFA-3, the CD2 ligand, specifically immobilizes major histocompatibility complex proteins. Eur J Immunol. 1989 Apr; 19(4):661-5.
      View in: PubMed
    159. Nishimura T, Burakoff SJ, Herrmann SH. Inhibition of lymphokine-activated killer cell-mediated cytotoxicity by phorbol ester. J Immunol. 1989 Mar 15; 142(6):2155-61.
      View in: PubMed
    160. Sleckman BP, Bigby M, Greenstein JL, Burakoff SJ, Sy MS. Requirements for modulation of the CD4 molecule in response to phorbol myristate acetate. Role of the cytoplasmic domain. J Immunol. 1989 Mar 1; 142(5):1457-62.
      View in: PubMed
    161. Stringfellow MM, Wilson RE, Burakoff SJ, Herrmann SH. Effect of timing of lymphokine presentation on generation of cytotoxic T lymphocytes. Arch Surg. 1989 Jan; 124(1):81-4.
      View in: PubMed
    162. Jones WK, Sen J, Burakoff SJ. Murine CD2: structure, expression, and recognition of human LFA-3. Year Immunol. 1989-1990; 6:95-111.
      View in: PubMed
    163. Strominger JL, Santos-Aguado J, Burakoff SJ, Vega MA, Gotch FM, Robbins PA, McMichael AJ. Mutants of HLA-A2 in the analysis of its structure and function. Cold Spring Harb Symp Quant Biol. 1989; 54 Pt 1:361-3.
      View in: PubMed
    164. Ferrara JL, Guillen FJ, van Dijken PJ, Marion A, Murphy GF, Burakoff SJ. Evidence that large granular lymphocytes of donor origin mediate acute graft-versus-host disease. Transplantation. 1989 Jan; 47(1):50-4.
      View in: PubMed
    165. Bierer BE, Sleckman BP, Ratnofsky SE, Burakoff SJ. The biologic roles of CD2, CD4, and CD8 in T-cell activation. Annu Rev Immunol. 1989; 7:579-99.
      View in: PubMed
    166. Strominger JL, Fabbi M, Prendergast M, Maziarz RT, Burakoff SJ, Groh V. Novel subsets of human T cells (CD4+ CD8- TCR gamma delta and CD4- CD8- TCR alpha beta) and T-cell development. Int J Cancer Suppl. 1989; 4:43-7.
      View in: PubMed
    167. Rosenstein Y, Ratnofsky S, Burakoff SJ, Herrmann SH. Direct evidence for binding of CD8 to HLA class I antigens. J Exp Med. 1989 Jan 1; 169(1):149-60.
      View in: PubMed
    168. Diamond DC, Sleckman BP, Gregory T, Lasky LA, Greenstein JL, Burakoff SJ. Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. J Immunol. 1988 Dec 1; 141(11):3715-7.
      View in: PubMed
    169. Bierer BE, Emerson SG, Antin J, Maziarz R, Rappeport JM, Smith BR, Burakoff SJ. Regulation of cytotoxic T lymphocyte-mediated graft rejection following bone marrow transplantation. Transplantation. 1988 Dec; 46(6):835-9.
      View in: PubMed
    170. Nishimura Y, Bierer BE, Burakoff SJ. Expression of CD5 regulates responsiveness to IL-1. J Immunol. 1988 Nov 15; 141(10):3438-44.
      View in: PubMed
    171. Petrarca MA, Reiss CS, Diamond DC, Boni J, Burakoff SJ, Faller DV. T cell hybridomas define the class II MHC-restricted response to vesicular stomatitis virus infection. Microb Pathog. 1988 Nov; 5(5):319-32.
      View in: PubMed
    172. Mentzer SJ, Wilson RE, Burakoff SJ, Herrmann SH. Membrane-bound anti-CD3 monoclonal antibodies trigger cytolytic T-lymphocyte-mediated tumor lysis. Arch Surg. 1988 Oct; 123(10):1280-5.
      View in: PubMed
    173. Sung KL, Sung LA, Crimmins M, Burakoff SJ, Chien S. Dynamic changes in viscoelastic properties in cytotoxic T-lymphocyte-mediated killing. J Cell Sci. 1988 Oct; 91 ( Pt 2):179-89.
      View in: PubMed
    174. Bierer BE, Peterson A, Gorga JC, Herrmann SH, Burakoff SJ. Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor. J Exp Med. 1988 Sep 1; 168(3):1145-56.
      View in: PubMed
    175. Mentzer SJ, Herrmann SH, Crimmins MA, Burakoff SJ, Faller DV. The role of CD18 in phorbol ester-induced human monocyte-mediated cytotoxicity. Cell Immunol. 1988 Aug; 115(1):66-77.
      View in: PubMed
    176. Macklis RM, Kaplan WD, Ferrara JL, Kinsey BM, Kassis AI, Burakoff SJ. Biodistribution studies of anti-Thy 1.2 IgM immunoconjugates: implications for radioimmunotherapy. Int J Radiat Oncol Biol Phys. 1988 Aug; 15(2):383-9.
      View in: PubMed
    177. Sleckman BP, Peterson A, Foran JA, Gorga JC, Kara CJ, Strominger JL, Burakoff SJ, Greenstein JL. Functional analysis of a cytoplasmic domain-deleted mutant of the CD4 molecule. J Immunol. 1988 Jul 1; 141(1):49-54.
      View in: PubMed
    178. Bierer BE, Burakoff SJ. T cell adhesion molecules. FASEB J. 1988 Jul; 2(10):2584-90.
      View in: PubMed
    179. Maziarz RT, Burakoff SJ, Bluestone JA. The alpha-3 domain of class I MHC proteins influences cytotoxic T lymphocyte recognition of antigenic determinants located within the alpha-1 and alpha-2 domains. J Immunol. 1988 Jun 15; 140(12):4372-7.
      View in: PubMed
    180. Macklis RM, Kinsey BM, Kassis AI, Ferrara JL, Atcher RW, Hines JJ, Coleman CN, Adelstein SJ, Burakoff SJ. Radioimmunotherapy with alpha-particle-emitting immunoconjugates. Science. 1988 May 20; 240(4855):1024-6.
      View in: PubMed
    181. Bierer BE, Barbosa J, Herrmann S, Burakoff SJ. Interaction of CD2 with its ligand, LFA-3, in human T cell proliferation. J Immunol. 1988 May 15; 140(10):3358-63.
      View in: PubMed
    182. Ferrara JL, Michaelson J, Burakoff SJ, Mauch P. Engraftment following T cell-depleted bone marrow transplantation. III. Differential effects of increased total-body irradiation on semiallogeneic and allogeneic recipients. Transplantation. 1988 May; 45(5):948-52.
      View in: PubMed
    183. Wall DA, Hamberg SD, Reynolds DS, Burakoff SJ, Abbas AK, Ferrara JL. Immunodeficiency in graft-versus-host disease. I. Mechanism of immune suppression. J Immunol. 1988 May 1; 140(9):2970-6.
      View in: PubMed
    184. Bierer BE, Nishimura Y, Burakoff SJ, Smith BR. Phenotypic and functional characterization of human cytolytic T cells lacking expression of CD5. J Clin Invest. 1988 May; 81(5):1390-7.
      View in: PubMed
    185. Nishimura Y, Bierer BE, Jones WK, Jones NH, Strominger JL, Burakoff SJ. Expression and function of a CD5 cDNA in human and murine T cells. Eur J Immunol. 1988 May; 18(5):747-53.
      View in: PubMed
    186. Bierer BE, Peterson A, Barbosa J, Seed B, Burakoff SJ. Expression of the T-cell surface molecule CD2 and an epitope-loss CD2 mutant to define the role of lymphocyte function-associated antigen 3 (LFA-3) in T-cell activation. Proc Natl Acad Sci U S A. 1988 Feb; 85(4):1194-8.
      View in: PubMed
    187. Takai Y, Wong GG, Clark SC, Burakoff SJ, Herrmann SH. B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J Immunol. 1988 Jan 15; 140(2):508-12.
      View in: PubMed
    188. Goldman SJ, Bierer BE, Burakoff SJ. Analysis of CD4 and CD2 receptor function. Princess Takamatsu Symp. 1988; 19:149-60.
      View in: PubMed
    189. Bierer BE, Greenstein JL, Sleckman B, Ratnofsky S, Peterson A, Seed B, Burakoff SJ. Functional analysis of CD2, CD4, and CD8 in T-cell activation. Ann N Y Acad Sci. 1988; 532:199-206.
      View in: PubMed
    190. Kinsey BM, Macklis RM, Ferrara JM, Layne WW, Burakoff SJ, Kassis AI. Efficient conjugation of DTPA to an IgM monoclonal antibody in ascites fluid. Int J Rad Appl Instrum B. 1988; 15(3):285-92.
      View in: PubMed
    191. Ratnofsky SE, Peterson A, Greenstein JL, Burakoff SJ. Expression and function of CD8 in a murine T cell hybridoma. J Exp Med. 1987 Dec 1; 166(6):1747-57.
      View in: PubMed
    192. Nishimura T, Burakoff SJ, Herrmann SH. Protein kinase C required for cytotoxic T lymphocyte triggering. J Immunol. 1987 Nov 1; 139(9):2888-91.
      View in: PubMed
    193. Barbosa JA, Santos-Aguado J, Mentzer SJ, Strominger JL, Burakoff SJ, Biro PA. Site-directed mutagenesis of class I HLA genes. Role of glycosylation in surface expression and functional recognition. J Exp Med. 1987 Nov 1; 166(5):1329-50.
      View in: PubMed
    194. Takai Y, Reed ML, Burakoff SJ, Herrmann SH. Direct evidence for a receptor-ligand interaction between the T-cell surface antigen CD2 and lymphocyte-function-associated antigen 3. Proc Natl Acad Sci U S A. 1987 Oct; 84(19):6864-8.
      View in: PubMed
    195. Ferrara JL, Mauch P, McIntyre J, Michaelson J, Burakoff SJ. Engraftment following T-cell-depleted bone marrow transplantation. II. Stability of mixed chimerism in semiallogeneic recipients after total-body irradiation. Transplantation. 1987 Oct; 44(4):495-9.
      View in: PubMed
    196. Daley JP, Rozans MK, Smith BR, Burakoff SJ, Rappeport JM, Miller RA. Retarded recovery of functional T cell frequencies in T cell-depleted bone marrow transplant recipients. Blood. 1987 Oct; 70(4):960-4.
      View in: PubMed
    197. Bierer BE, Herrmann SH, Brown CS, Burakoff SJ, Golan DE. Lateral mobility of class I histocompatibility antigens in B lymphoblastoid cell membranes: modulation by cross-linking and effect of cell density. J Cell Biol. 1987 Sep; 105(3):1147-52.
      View in: PubMed
    198. Sleckman BP, Peterson A, Jones WK, Foran JA, Greenstein JL, Seed B, Burakoff SJ. Expression and function of CD4 in a murine T-cell hybridoma. Nature. 1987 Jul 23-29; 328(6128):351-3.
      View in: PubMed
    199. Rosoff PM, Burakoff SJ, Greenstein JL. The role of the L3T4 molecule in mitogen and antigen-activated signal transduction. Cell. 1987 Jun 19; 49(6):845-53.
      View in: PubMed
    200. Ferrara JL, Daley JP, Burakoff SJ, Miller RA. Functional T cell deficits after bone marrow transplantation across minor histocompatibility barriers: effects of graft-vs-host disease on precursor frequency of reactive cells. J Immunol. 1987 Jun 1; 138(11):3598-603.
      View in: PubMed
    201. Mentzer SJ, Remold-O'Donnell E, Crimmins MA, Bierer BE, Rosen FS, Burakoff SJ. Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation. J Exp Med. 1987 May 1; 165(5):1383-92.
      View in: PubMed
    202. Ferrara J, Lipton J, Hellman S, Burakoff S, Mauch P. Engraftment following T-cell-depleted marrow transplantation. I. The role of major and minor histocompatibility barriers. Transplantation. 1987 Apr; 43(4):461-7.
      View in: PubMed
    203. Mentzer SJ, Smith BR, Barbosa JA, Crimmins MA, Herrmann SH, Burakoff SJ. CTL adhesion and antigen recognition are discrete steps in the human CTL-target cell interaction. J Immunol. 1987 Mar 1; 138(5):1325-30.
      View in: PubMed
    204. Mentzer SJ, Crimmins MA, Burakoff SJ, Faller DV. Alpha and beta subunits of the LFA-1 membrane molecule are involved in human monocyte-endothelial cell adhesion. J Cell Physiol. 1987 Mar; 130(3):410-5.
      View in: PubMed
    205. Ferrara J, Marion A, Murphy G, Burakoff S. Acute graft-versus-host disease: pathogenesis and prevention with a monoclonal antibody in vivo. Transplant Proc. 1987 Feb; 19(1 Pt 3):2662-3.
      View in: PubMed
    206. Greenstein JL, Sitkovsky MV, Burakoff SJ. Distinct roles for L3T4 in T cell activation. Fed Proc. 1987 Feb; 46(2):313-6.
      View in: PubMed
    207. Greenstein JL, Burakoff SJ. The role of L3T4 (CD4) in T-cell activation. Ann Inst Pasteur Immunol. 1987 Jan-Feb; 138(1):134-8.
      View in: PubMed
    208. Flyer DC, Burakoff SJ, Faller DV. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens. J Immunol. 1986 Dec 15; 137(12):3968-72.
      View in: PubMed
    209. Sung KL, Sung LA, Crimmins M, Burakoff SJ, Chien S. Determination of junction avidity of cytolytic T cell and target cell. Science. 1986 Dec 12; 234(4782):1405-8.
      View in: PubMed
    210. Takai Y, Herrmann SH, Greenstein JL, Spitalny GL, Burakoff SJ. Requirement for three distinct lymphokines for the induction of cytotoxic T lymphocytes from thymocytes. J Immunol. 1986 Dec 1; 137(11):3494-500.
      View in: PubMed
    211. Gorga JC, Knudsen PJ, Foran JA, Strominger JL, Burakoff SJ. Immunochemically purified DR antigens in liposomes stimulate xenogeneic cytolytic T cells in secondary in vitro cultures. Cell Immunol. 1986 Nov; 103(1):160-73.
      View in: PubMed
    212. Mentzer SJ, Bierer BE, Anderson DC, Springer TA, Burakoff SJ. Abnormal cytolytic activity of lymphocyte function-associated antigen-1-deficient human cytolytic T lymphocyte clones. J Clin Invest. 1986 Nov; 78(5):1387-91.
      View in: PubMed
    213. Mentzer SJ, Krensky AM, Burakoff SJ. Mapping functional epitopes of the human LFA-1 glycoprotein: monoclonal antibody inhibition of NK and CTL effectors. Hum Immunol. 1986 Nov; 17(3):288-96.
      View in: PubMed
    214. Rozans MK, Smith BR, Emerson S, Crimmins M, Laurent G, Reichert T, Burakoff SJ, Miller RA. Functional assessment of T cell depletion from bone marrow prior to therapeutic transplantation using limiting dilution culture methods. Transplantation. 1986 Oct; 42(4):380-7.
      View in: PubMed
    215. Ferrara JL, Marion A, McIntyre JF, Murphy GF, Burakoff SJ. Amelioration of acute graft vs host disease due to minor histocompatibility antigens by in vivo administration of anti-interleukin 2 receptor antibody. J Immunol. 1986 Sep 15; 137(6):1874-7.
      View in: PubMed
    216. Mentzer SJ, Guyre PM, Burakoff SJ, Faller DV. Spontaneous aggregation as a mechanism for human monocyte purification. Cell Immunol. 1986 Sep; 101(2):312-9.
      View in: PubMed
    217. Mentzer SJ, Barbosa JA, Strominger JL, Biro PA, Burakoff SJ. Species-restricted recognition of transfected HLA-A2 and HLA-B7 by human CTL clones. J Immunol. 1986 Jul 15; 137(2):408-13.
      View in: PubMed
    218. Greenstein JL, Herrmann SH, Sunshine GH, Burakoff SJ. The mechanism of antigen presentation by dendritic cells and splenic adherent cells in the induction of an allogeneic cytotoxic T-lymphocyte response to H-2Kk liposomes. Cell Immunol. 1986 Jul; 100(2):389-99.
      View in: PubMed
    219. Guillén FJ, Ferrara J, Hancock WW, Messadi D, Fonferko E, Burakoff SJ, Murphy GF. Acute cutaneous graft-versus-host disease to minor histocompatibility antigens in a murine model. Evidence that large granular lymphocytes are effector cells in the immune response. Lab Invest. 1986 Jul; 55(1):35-42.
      View in: PubMed
    220. Mentzer SJ, Faller DV, Burakoff SJ. Interferon-gamma induction of LFA-1-mediated homotypic adhesion of human monocytes. J Immunol. 1986 Jul 1; 137(1):108-13.
      View in: PubMed
    221. Rozans MK, Smith BR, Burakoff SJ, Miller RA. Long-lasting deficit of functional T cell precursors in human bone marrow transplant recipients revealed by limiting dilution methods. J Immunol. 1986 Jun 1; 136(11):4040-8.
      View in: PubMed
    222. Barbosa JA, Mentzer SJ, Kamarck ME, Hart J, Biro PA, Strominger JL, Burakoff SJ. Gene mapping and somatic cell hybrid analysis of the role of human lymphocyte function-associated antigen-3 (LFA-3) in CTL-target cell interactions. J Immunol. 1986 Apr 15; 136(8):3085-91.
      View in: PubMed
    223. Maziarz RT, Burakoff SJ, Reiss CS. Viral-restricted cytolytic T lymphocyte recognition of hybrid human-murine class I histocompatibility antigens. Cell Immunol. 1986 Apr 15; 99(1):279-86.
      View in: PubMed
    224. Greenstein JL, Foran JA, Gorga JC, Burakoff SJ. The role of T cell accessory molecules in the generation of class II-specific xenogeneic cytolytic T cells. J Immunol. 1986 Apr 1; 136(7):2358-63.
      View in: PubMed
    225. Ferrara J, Guillen FJ, Sleckman B, Burakoff SJ, Murphy GF. Cutaneous acute graft-versus-host disease to minor histocompatibility antigens in a murine model: histologic analysis and correlation to clinical disease. J Invest Dermatol. 1986 Apr; 86(4):371-5.
      View in: PubMed
    226. Murre C, Parker KC, Reiss CS, Driller JP, Wiley DC, Burakoff SJ, Seidman JG. Biochemical and functional analyses of a secreted H-2Ld molecule. Mol Cell Biol. 1986 Apr; 6(4):1315-9.
      View in: PubMed
    227. Reiss CS, Greenstein JL, Crimmins MA, Liu LL, Rao A, Maziaraz RT, Murre C, Burakoff SJ. Recognition of the alpha-1 and alpha-2 domains of H-2 molecules by allospecific cloned T cells. J Immunol. 1986 Mar 15; 136(6):2191-4.
      View in: PubMed
    228. Mentzer SJ, Burakoff SJ, Faller DV. Adhesion of T lymphocytes to human endothelial cells is regulated by the LFA-1 membrane molecule. J Cell Physiol. 1986 Feb; 126(2):285-90.
      View in: PubMed
    229. Maziarz RT, Fraser J, Strominger JL, Burakoff SJ. The human HLA-specific monoclonal antibody W6/32 recognizes a discontinuous epitope within the alpha 2 domain of murine H-2Db. Immunogenetics. 1986; 24(3):206-8.
      View in: PubMed
    230. Bierer BE, Mentzer SJ, Greenstein JL, Burakoff SJ. The role of functional cell surface antigens in T cell activation. Year Immunol. 1986; 2:39-59.
      View in: PubMed
    231. Krensky AM, Mentzer SJ, Clayberger C, Anderson DC, Schmalstieg FC, Burakoff SJ, Springer TA. Heritable lymphocyte function-associated antigen-1 deficiency: abnormalities of cytotoxicity and proliferation associated with abnormal expression of LFA-1. J Immunol. 1985 Nov; 135(5):3102-8.
      View in: PubMed
    232. Weinberger O, Herrmann SH, Greenstein JL, Mescher MF, Burakoff SJ. The ability of Ia and H-2Kk-bearing membranes to replace the antigen-presenting cell in an H-2Kk allogeneic cytotoxic T cell response. Eur J Immunol. 1985 Oct; 15(10):1013-8.
      View in: PubMed
    233. Flyer DC, Burakoff SJ, Faller DV. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes. J Immunol. 1985 Oct; 135(4):2287-92.
      View in: PubMed
    234. Heilig JS, Glimcher LH, Kranz DM, Clayton LK, Greenstein JL, Saito H, Maxam AM, Burakoff SJ, Eisen HN, Tonegawa S. Expression of the T-cell-specific gamma gene is unnecessary in T cells recognizing class II MHC determinants. Nature. 1985 Sep 5-11; 317(6032):68-70.
      View in: PubMed
    235. Maziarz R, Allen H, Strominger JL, Flavell R, Biro PA, Burakoff SJ. Recognition of interspecies hybrid class I histocompatibility antigens by antigen-specific cytolytic T lymphocytes. Proc Natl Acad Sci U S A. 1985 Sep; 82(18):6276-80.
      View in: PubMed
    236. Mentzer SJ, Gromkowski SH, Krensky AM, Burakoff SJ, Martz E. LFA-1 membrane molecule in the regulation of homotypic adhesions of human B lymphocytes. J Immunol. 1985 Jul; 135(1):9-11.
      View in: PubMed
    237. Greenstein JL, Malissen B, Burakoff SJ. Role of L3T4 in antigen-driven activation of a class I-specific T cell hybridoma. J Exp Med. 1985 Jul 1; 162(1):369-74.
      View in: PubMed
    238. Umetsu DT, Pober JS, Jabara HH, Fiers W, Yunis EJ, Burakoff SJ, Reiss CS, Geha RS. Human dermal fibroblasts present tetanus toxoid antigen to antigen-specific T cell clones. J Clin Invest. 1985 Jul; 76(1):254-60.
      View in: PubMed
    239. Mentzer SJ, Barbosa JA, Burakoff SJ. T3 monoclonal antibody activation of nonspecific cytolysis: a mechanism of CTL inhibition. J Immunol. 1985 Jul; 135(1):34-8.
      View in: PubMed
    240. Weis JH, Reiss CS, Mulligan RC, Burakoff SJ, Seidman JG. H-2Ld antigen encoded by a recombinant retrovirus genome is expressed on the surface of infected cells. Mol Cell Biol. 1985 Jun; 5(6):1379-84.
      View in: PubMed
    241. Miller BA, Lipton JM, Linch DC, Burakoff SJ, Nathan DG. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors. J Cell Physiol. 1985 Apr; 123(1):25-32.
      View in: PubMed
    242. O'Flynn K, Krensky AM, Beverley PC, Burakoff SJ, Linch DC. Phytohaemagglutinin activation of T cells through the sheep red blood cell receptor. Nature. 1985 Feb 21-27; 313(6004):686-7.
      View in: PubMed
    243. Springer TA, Rothlein R, Anderson DC, Burakoff SJ, Krensky AM. The function of LFA-1 in cell-mediated killing and adhesion: studies on heritable LFA-1, Mac-1 deficiency and on lymphoid cell self-aggregation. Adv Exp Med Biol. 1985; 184:311-22.
      View in: PubMed
    244. Gromkowski SH, Krensky AM, Martz E, Burakoff SJ. Functional distinctions between the LFA-1, LFA-2, and LFA-3 membrane proteins on human CTL are revealed with trypsin-pretreated target cells. J Immunol. 1985 Jan; 134(1):244-9.
      View in: PubMed
    245. Ferrara J, Mauch P, Murphy G, Burakoff SJ. Bone marrow transplantation: the genetic and cellular basis of resistance to engraftment and acute graft-versus-host disease. Surv Immunol Res. 1985; 4(4):253-63.
      View in: PubMed
    246. Flyer DC, Burakoff SJ, Faller DV. Expression and CTL recognition of cloned subgenomic fragments of Moloney murine leukemia virus in murine cells. Surv Immunol Res. 1985; 4(2):168-72.
      View in: PubMed
    247. Pober JS, Gimbrone MA, Collins T, Cotran RS, Ault KA, Fiers W, Krensky AM, Clayberger C, Reiss CS, Burakoff SJ. Interactions of T lymphocytes with human vascular endothelial cells: role of endothelial cells surface antigens. Immunobiology. 1984 Dec; 168(3-5):483-94.
      View in: PubMed
    248. Bernabeu C, Maziarz R, Spits H, de Vries J, Burakoff SJ, Terhorst C. Coexpression of the human HLA-A2 or HLA-B7 heavy chain gene and human beta 2-microglobulin gene in L cells. J Immunol. 1984 Dec; 133(6):3188-94.
      View in: PubMed
    249. Barbosa JA, Mentzer SJ, Minowada G, Strominger JL, Burakoff SJ, Biro PA. Recognition of HLA-A2 and -B7 antigens by cloned cytotoxic T lymphocytes after gene transfer into human and monkey, but not mouse, cells. Proc Natl Acad Sci U S A. 1984 Dec; 81(23):7549-53.
      View in: PubMed
    250. Stallcup KC, Burakoff SJ, Mescher MF. Inhibition of normal lymphocyte responses by cell membranes. Cell Immunol. 1984 Nov; 89(1):144-50.
      View in: PubMed
    251. Greenberger JS, Krensky AM, Messner H, Burakoff SJ, Wandl U, Sakakeeny MA. Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes. Exp Hematol. 1984 Oct; 12(9):720-7.
      View in: PubMed
    252. Collins T, Krensky AM, Clayberger C, Fiers W, Gimbrone MA, Burakoff SJ, Pober JS. Human cytolytic T lymphocyte interactions with vascular endothelium and fibroblasts: role of effector and target cell molecules. J Immunol. 1984 Oct; 133(4):1878-84.
      View in: PubMed
    253. Stallcup KC, Burakoff SJ, Mescher MF. Growth-inhibitory activity of lymphoid cell plasma membranes. II. Partial characterization of the inhibitor. J Cell Biol. 1984 Oct; 99(4 Pt 1):1227-34.
      View in: PubMed
    254. Murre C, Choi E, Weis J, Seidman JG, Ozato K, Liu L, Burakoff SJ, Reiss CS. Dissection of serological and cytolytic T lymphocyte epitopes on murine major histocompatibility antigens by a recombinant H-2 gene separating the first two external domains. J Exp Med. 1984 Jul 1; 160(1):167-78.
      View in: PubMed
    255. Hemler ME, Sanchez-Madrid F, Flotte TJ, Krensky AM, Burakoff SJ, Bhan AK, Springer TA, Strominger JL. Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines. J Immunol. 1984 Jun; 132(6):3011-8.
      View in: PubMed
    256. Krensky AM, Robbins E, Springer TA, Burakoff SJ. LFA-1, LFA-2, and LFA-3 antigens are involved in CTL-target conjugation. J Immunol. 1984 May; 132(5):2180-2.
      View in: PubMed
    257. Duprez V, Maziarz R, Weinberger O, Burakoff SJ. Thymectomized, irradiated, and bone marrow-reconstituted chimeras have normal cytolytic T lymphocyte precursors but a defect in lymphokine production. J Immunol. 1984 May; 132(5):2185-9.
      View in: PubMed
    258. Greenstein JL, Kappler J, Marrack P, Burakoff SJ. The role of L3T4 in recognition of Ia by a cytotoxic, H-2Dd-specific T cell hybridoma. J Exp Med. 1984 Apr 1; 159(4):1213-24.
      View in: PubMed
    259. Murre C, Reiss CS, Bernabeu C, Chen LB, Burakoff SJ, Seidman JG. Construction, expression and recognition of an H-2 molecule lacking its carboxyl terminus. Nature. 1984 Feb 2-8; 307(5950):432-6.
      View in: PubMed
    260. Burakoff SJ. Cell-mediated cytotoxicity. An overview. Fed Proc. 1984 Feb; 43(2):266-7.
      View in: PubMed
    261. Reiss CS, Evans GA, Murre C, Margulies DH, Seidman JG, Burakoff SJ. Cytotoxic T lymphocyte recognition of class I H-2 antigens after DNA-mediated gene transfer. Fed Proc. 1984 Feb; 43(2):271-5.
      View in: PubMed
    262. Greenberger JS, Sakakeeny MA, Krensky A, Burakoff S, Reid D, Novak T, Boggs SS. Experimental evidence for the potential usefulness of permanent IL-3-dependent multipotential hematopoietic progenitor cell lines in transfusion granulocyte support therapy: need for expansion of early passage cells. Kroc Found Ser. 1984; 18:255-69.
      View in: PubMed
    263. Gorga JC, Foran J, Burakoff SJ, Strominger JL. Use of the HLA-DR antigens incorporated into liposomes to generate HLA-DR specific cytotoxic T lymphocytes. Methods Enzymol. 1984; 108:607-13.
      View in: PubMed
    264. Krensky AM, Sanchez-Madrid F, Springer TA, Burakoff SJ. Human lymphocyte function-associated antigens. Surv Immunol Res. 1984; 3(1):39-44.
      View in: PubMed
    265. Burakoff SJ, Weinberger O, Krensky AM, Reiss CS. A molecular analysis of the cytolytic T lymphocyte response. Adv Immunol. 1984; 36:45-85.
      View in: PubMed
    266. Krensky AM, Clayberger C, Greenstein JL, Crimmins M, Burakoff SJ. A DC-specific cytolytic T lymphocyte line is OKT8+1. J Immunol. 1983 Dec; 131(6):2777-80.
      View in: PubMed
    267. Pober JS, Collins T, Gimbrone MA, Cotran RS, Gitlin JD, Fiers W, Clayberger C, Krensky AM, Burakoff SJ, Reiss CS. Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature. 1983 Oct 20-26; 305(5936):726-9.
      View in: PubMed
    268. Flyer DC, Burakoff SJ, Faller DV. Cytotoxic T lymphocyte recognition of transfected cells expressing a cloned retroviral gene. Nature. 1983 Oct 27-Nov 2; 305(5937):815-8.
      View in: PubMed
    269. Burakoff SJ, Lipton JM, Nathan DG. Recapitulation of the immune response and haematopoietic system in bone marrow transplantation. Clin Haematol. 1983 Oct; 12(3):695-720.
      View in: PubMed
    270. Ware CF, Krangel MS, Pious D, Burakoff SJ, Strominger JL. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line. J Immunol. 1983 Sep; 131(3):1312-7.
      View in: PubMed
    271. Ware CF, Sanchez-Madrid F, Krensky AM, Burakoff SJ, Strominger JL, Springer TA. Human lymphocyte function associated antigen-1 (LFA-1): identification of multiple antigenic epitopes and their relationship to CTL-mediated cytotoxicity. J Immunol. 1983 Sep; 131(3):1182-8.
      View in: PubMed
    272. Krensky AM, Sanchez-Madrid F, Robbins E, Nagy JA, Springer TA, Burakoff SJ. The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions. J Immunol. 1983 Aug; 131(2):611-6.
      View in: PubMed
    273. Ben-Nun A, Lando Z, Dorf ME, Burakoff SJ. Analysis of cross-reactive antigen-specific T cell clones. Specific recognition of two major histocompatibility complex (MHC) and two non-MHC antigens by a single clone. J Exp Med. 1983 Jun 1; 157(6):2147-53.
      View in: PubMed
    274. Krensky AM, Burakoff SJ. Basic science seminar: cytotoxic T-lymphocyte response to HLA antigens. J Pediatr. 1983 Jun; 102(6):814-9.
      View in: PubMed
    275. Reiss CS, Evans GA, Margulies DH, Seidman JG, Burakoff SJ. Allospecific and virus-specific cytolytic T lymphocytes are restricted to the N or C1 domain of H-2 antigens expressed on L cells after DNA-mediated gene transfer. Proc Natl Acad Sci U S A. 1983 May; 80(9):2709-12.
      View in: PubMed
    276. Pober JS, Gimbrone MA, Cotran RS, Reiss CS, Burakoff SJ, Fiers W, Ault KA. Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon. J Exp Med. 1983 Apr 1; 157(4):1339-53.
      View in: PubMed
    277. Weinberger O, Germain RN, Burakoff SJ. Responses to the H-2Kba mutant involve recognition of syngeneic Ia molecules. Nature. 1983 Mar 31-Apr 6; 302(5907):429-31.
      View in: PubMed
    278. Duprez V, Mescher MF, Burakoff SJ. Stimulation of secondary anti-MSV cytolytic T lymphocytes with MBL-2 reconstituted membranes. J Immunol. 1983 Jan; 130(1):493-5.
      View in: PubMed
    279. Duprez V, Burakoff SJ. Cytolytic T lymphocyte response to Moloney sarcoma virus. Surv Immunol Res. 1983; 2(3):309-11.
      View in: PubMed
    280. Burakoff SJ, Clayberger C, Hemler M, Krensky AM, Reiss CS, Robbins E, Sanchez-Madrid F, Springer TA, Strominger JL, Ware CF. Cytotoxic T cells directed against HLA-DR antigens and their surface proteins. Diagn Immunol. 1983; 1(3):116-9.
      View in: PubMed
    281. Sanchez-Madrid F, Krensky AM, Ware CF, Robbins E, Strominger JL, Burakoff SJ, Springer TA. Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc Natl Acad Sci U S A. 1982 Dec; 79(23):7489-93.
      View in: PubMed
    282. Krensky AM, Clayberger C, Reiss CS, Strominger JL, Burakoff SJ. Specificity of OKT4+ cytotoxic T lymphocyte clones. J Immunol. 1982 Nov; 129(5):2001-3.
      View in: PubMed
    283. Krensky AM, Ault KA, Reiss CS, Strominger JL, Burakoff SJ. Generation of long-term human cytolytic cell lines with persistent natural killer activity. J Immunol. 1982 Oct; 129(4):1748-51.
      View in: PubMed
    284. Duprez V, Hamilton B, Burakoff SJ. Generation of cytolytic T lymphocytes in thymectomized, irradiated, and bone marrow-reconstituted mice. J Exp Med. 1982 Sep 1; 156(3):844-59.
      View in: PubMed
    285. Weinberger O, Germain RN, Springer T, Burakoff SJ. Role of syngeneic Ia+ accessory cells in the generation of allospecific CTL responses. J Immunol. 1982 Aug; 129(2):694-7.
      View in: PubMed
    286. Moser G, Burakoff SJ, Abbas AK. Suppression of anti-hapten antibody responses by hapten-specific cytolytic T lymphocytes: role of I-A-associated antigen on target B lymphocytes. J Immunol. 1982 Jul; 129(1):63-9.
      View in: PubMed
    287. Herrmann SH, Weinberger O, Burakoff SJ, Mescher MF. Analysis of the two-signal requirement for precursor cytolytic T lymphocyte activation using H-2Kk in liposomes. J Immunol. 1982 May; 128(5):1968-74.
      View in: PubMed
    288. Reiss CS, Dorf ME, Benacerraf B, Burakoff SJ. Genetic control of the cytolytic T lymphocyte response to influenza viruses: H-2 genes influence the response to H-2Kb plus virus. J Immunol. 1982 May; 128(5):2295-9.
      View in: PubMed
    289. Gualde N, Weinberger O, Ratnofsky S, Benacerraf B, Burakoff SJ. In vitro generation of helper T cells and suppressor T cells that regulate the cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. Transplantation. 1982 Apr; 33(4):422-6.
      View in: PubMed
    290. Krensky AM, Reiss CS, Mier JW, Strominger JL, Burakoff SJ. Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+. Proc Natl Acad Sci U S A. 1982 Apr; 79(7):2365-9.
      View in: PubMed
    291. Greene MI, Ratnofsky S, Takaoki M, Sy MS, Burakoff S, Finberg RW. Antigen-specific suppression of cytotoxic T cell responses: an idiotype-bearing factor regulates the cytotoxic T cell response to azobenzenearsonate-coupled cells. J Immunol. 1982 Mar; 128(3):1188-91.
      View in: PubMed
    292. Mescher MF, Balk SP, Burakoff SJ, Herrmann SH. Cytolytic T lymphocyte recognition of subcellular antigen. Adv Exp Med Biol. 1982; 146:41-55.
      View in: PubMed
    293. Shapiro ME, Burakoff SJ, Benacerraf B, Finberg RW. Ir gene control of the cytotoxic T lymphocyte response to Sendai virus: H-2k mice are low responders to Sendai. J Immunol. 1981 Dec; 127(6):2571-4.
      View in: PubMed
    294. Reiss CS, Burakoff SJ. Specificity of the helper T cell for the cytolytic T lymphocyte response to influenza viruses. J Exp Med. 1981 Aug 1; 154(2):541-6.
      View in: PubMed
    295. Weinberger O, Herrmann S, Mescher MF, Benacerraf B, Burakoff SJ. Cellular interactions in the generation of cytolytic T lymphocyte responses. Analysis of the helper T cell pathway. Eur J Immunol. 1981 May; 11(5):405-11.
      View in: PubMed
    296. Burakoff SJ, Weinberger O, Herrmann SH, Mescher MF. Cellular interactions in the regulation of the cytolytic T-lymphocyte response: the effect of suboptimal antigen dose. Transplant Proc. 1981 Mar; 13(1 Pt 2):1039-41.
      View in: PubMed
    297. Weinberger O, Herrmann S, Mescher MF, Benacerraf B, Burakoff SJ. Antigen-presenting cell function in induction of helper T cells for cytotoxic T-lymphocyte responses: evidence for antigen processing. Proc Natl Acad Sci U S A. 1981 Mar; 78(3):1796-9.
      View in: PubMed
    298. Finberg R, Weiner HL, Burakoff SJ, Fields BN. Type-specific reovirus antiserum blocks the cytotoxic T-cell-target cell interaction: evidence for the association of the viral hemagglutinin of a nonenveloped virus with the cell surface. Infect Immun. 1981 Feb; 31(2):646-9.
      View in: PubMed
    299. Abbas AK, Burakoff SJ, Gefter ML, Greene MI. T lymphocyte-mediated suppression of myeloma function in vitro. III. Regulation of antibody production in hybrid myeloma cells by T lymphocytes. J Exp Med. 1980 Oct 1; 152(4):969-78.
      View in: PubMed
    300. Weinberger O, Herrmann SH, Mescher MF, Benacerraf B, Burakoff SJ. Cellular interactions in the generation of cytolytic T lymphocyte responses: role of Ia-positive splenic adherent cells in presentation in H-2 antigen. Proc Natl Acad Sci U S A. 1980 Oct; 77(10):6091-5.
      View in: PubMed
    301. Burakoff SJ, Riccio J, Billings P, Benacerraf B, Dorf ME. Genetic control of cytolytic T lymphocyte responses. III. The role of K and I region alleles on the specificity of the cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. J Immunol. 1980 Oct; 125(4):1432-5.
      View in: PubMed
    302. Reiss CS, Hemler ME, Englehard VH, Mier JW, Strominger JL, Burakoff SJ. Development and characterization of allospecific long-term human cytolytic T-cell lines. Proc Natl Acad Sci U S A. 1980 Sep; 77(9):5432-6.
      View in: PubMed
    303. Engelhard VH, Kaufman JF, Strominger JL, Burakoff SJ. Specificity of mouse cytotoxic T lymphocytes stimulated with either HLA-A and -B or HLA-DR antigens reconstituted into phospholipid vesicles. J Exp Med. 1980 Aug 1; 152(2 Pt 2):54s-64s.
      View in: PubMed
    304. Abbas AK, Ratnofsky SE, Burakoff SJ. T lymphocyte-mediated suppression of myeloma function in vitro. II. Evidence for regulation of hapten-binding myelomas by syngeneic hapten-specific cytolytic T lymphocytes. J Exp Med. 1980 Aug 1; 152(2):306-23.
      View in: PubMed
    305. Brown AP, Burakoff SJ, Sher A. Specificity of alloreactive T lymphocytes that adhere to lung stage schistosomula of Schistosoma mansoni. J Immunol. 1980 May; 124(5):2516-8.
      View in: PubMed
    306. Sherman L, Burakoff SJ, Mescher MF. Induction of allogeneic cytolytic T lymphocytes by partially purified membrane glycoproteins. Cell Immunol. 1980 Apr; 51(1):141-50.
      View in: PubMed
    307. Finberg R, Cantor H, Benacerraf B, Burakoff S. The origins of alloreactivity: differentiation of prekiller cells to viral infection results in alloreactive cytolytic T lymphocytes. J Immunol. 1980 Apr; 124(4):1858-60.
      View in: PubMed
    308. Burakoff SJ, Engelhard VH, Kaufman J, Strominger JL. Induction of secondary cytotoxic T lymphocytes by liposomes containing HLA-DR antigens. Nature. 1980 Jan 31; 283(5746):495-7.
      View in: PubMed
    309. Burakoff SJ, Reiss CS, Finberg R, Mescher MF. Cell-mediated immunity to viral glycoproteins. Rev Infect Dis. 1980 Jan-Feb; 2(1):62-78.
      View in: PubMed
    310. Finberg R, Burakoff SJ, Benacerraf B, Greene MI. The cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. II. Evidence for antigen-specific suppressor T cells. J Immunol. 1979 Sep; 123(3):1210-4.
      View in: PubMed
    311. Finberg R, Greene MI, Benacerraf B, Burakoff SJ. The cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. I. Evidence for antigen-specific helper T cells. J Immunol. 1979 Sep; 123(3):1205-9.
      View in: PubMed
    312. Sherman L, Mescher MF, Burakoff SJ. The induction of cytolytic T lymphocytes with syngeneic trinitrophenyl-coupled membranes. J Immunol. 1979 Jul; 123(1):501-2.
      View in: PubMed
    313. Vadas MA, Butterworth AE, Burakoff S, Sher A. Major histocompatibility complex products restrict the adherence of cytolytic T lymphocytes to minor histocompatibility antigens or to trinitrophenyl determinants on schistosomula of Schistosoma mansoni. Proc Natl Acad Sci U S A. 1979 Apr; 76(4):1982-5.
      View in: PubMed
    314. Finberg R, Weiner HL, Fields BN, Benacerraf B, Burakoff SJ. Generation of cytolytic T lymphocytes after reovirus infection: role of S1 gene. Proc Natl Acad Sci U S A. 1979 Jan; 76(1):442-6.
      View in: PubMed
    315. Finberg R, Mescher M, Burakoff SJ. The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins. J Exp Med. 1978 Dec 1; 148(6):1620-7.
      View in: PubMed
    316. Engelhard VH, Strominger JL, Mescher M, Burakoff S. Induction of secondary cytotoxic T lymphocytes by purified HLA-A and HLA-B antigens reconstituted into phospholipid vesicles. Proc Natl Acad Sci U S A. 1978 Nov; 75(11):5688-91.
      View in: PubMed
    317. Burakoff SJ, Finberg R, Glimcher L, Lemonnier F, Benacerraf B, Cantor H. The biologic significance of alloreactivity. The ontogeny of T-cell sets specific for alloantigens or modified self antigens. J Exp Med. 1978 Nov 1; 148(5):1414-22.
      View in: PubMed
    318. Finberg R, Burakoff SJ, Cantor H, Benacerraf B. Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells. Proc Natl Acad Sci U S A. 1978 Oct; 75(10):5145-9.
      View in: PubMed
    319. Sherman LA, Burakoff SJ, Benacerraf B. The induction of cytolytic T lymphocytes with specificity for p-azophenylarsonate coupled syngeneic cells. J Immunol. 1978 Oct; 121(4):1432-6.
      View in: PubMed
    320. Billings P, Burakoff SJ, Dorf ME, Benacerraf B. Genetic control of cytolytic T-lymphocyte responses. I. Ir gene control of the specificity of cytolytic T-lymphocyte responses to trinitrophenyl-modified syngeneic cells. J Exp Med. 1978 Aug 1; 148(2):341-50.
      View in: PubMed
    321. Billings P, Burakoff SJ, Dorf ME, Benacerraf B. Genetic control of cytolytic t-lymphocyte responses. II. The role of the host genotype in parental leads to F1 radiation chimeras in the control of the specificity of cytolytic T-lymphocyte responses to trinitrophenyl-modified syngeneic cells. J Exp Med. 1978 Aug 1; 148(2):352-9.
      View in: PubMed
    322. Lemonnier F, Burakoff SJ, Mescher M, Dorf ME, Benacerraf B. Inhibition of the induction of cytolytic T lymphocytes with alloantisera directed against H-2K and H-2D gene products. J Immunol. 1978 May; 120(5):1717-20.
      View in: PubMed
    323. Lemonnier F, Mescher TM, sherman L, Burakoff S. The induction of cytolytic T lymphocytes with purified plasma membranes. J Immunol. 1978 Apr; 120(4):1114-20.
      View in: PubMed
    324. Mescher M, Sherman L, Lemonnier F, Burakoff S. The induction of secondary cytolytic T lymphocytes by solubilized membrane proteins. J Exp Med. 1978 Mar 1; 147(3):946-51.
      View in: PubMed
    325. Burakoff SJ, Ratnofsky SE, Benacerraf B. Mouse cytolytic T lymphocytes induced by xenogeneic rat stimulator cells exhibit specificity for H-2 complex alloantigens. Proc Natl Acad Sci U S A. 1977 Oct; 74(10):4572-6.
      View in: PubMed
    326. Billings P, Burakoff S, Dorf ME, Benacerraf B. Cytotoxic T lymphocytes induced against allogeneic I-region determinants react with Ia molecules on trinitrophenyl-conjugated syngeneic target cells. J Exp Med. 1977 Aug 1; 146(2):623-8.
      View in: PubMed
    327. Billings P, Burakoff S, Dorf ME, Benacerraf B. Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products. J Exp Med. 1977 May 1; 145(5):1387-92.
      View in: PubMed
    328. Burakoff SJ, Dorf ME, Benacerraf B. Specificity of rat xenogeneic cell-mediated cytolysis for the products of the K and D loci of the mouse H-2 complex. J Immunol. 1977 May; 118(5):1795-8.
      View in: PubMed
    329. Burakoff SJ, Germain RN, Benacerraf B. Cross-reactive lysis of trinitrophenyl (TNP)-derivatized H-2 incompatible target cells by cytolytic T lymphocytes generated against syngeneic TNP spleen cells. J Exp Med. 1976 Dec 1; 144(6):1609-20.
      View in: PubMed
    330. Burakoff SJ, Germain RN, Dorf ME, Benacerrah B. Inhibition of cell-mediated cytolysis of trinitrophenyl-derivatized target cells by alloantisera directed to the products of the K and D loci of the H-2 complex. Proc Natl Acad Sci U S A. 1976 Feb; 73(2):625-9.
      View in: PubMed
    331. Burakoff SJ, Martz E, Benacerraf B. Is the primary complement lesion insufficient for lysis? Failure of cells damaged under osmotic protection to lyse in EDTA or at low temperature after removal of osmotic protection. Clin Immunol Immunopathol. 1975 May; 4(1):108-26.
      View in: PubMed
    332. Martz E, Burakoff SJ, Benacerraf B. Interruption of the sequential release of small and large molecules from tumor cells by low temperature during cytolysis mediated by immune T-cells or complement. Proc Natl Acad Sci U S A. 1974 Jan; 71(1):177-81.
      View in: PubMed
    Burakoff's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067